The influence of sterilized and non-sterilized amniotic dressings on the proliferation of endothelial cells in vitro

Central-European Journal of Immunology

Volumn 37, Issue 2, 2012, Pages 114-118

  Skopiński, Piotr ^a,b   Zdanowski, Robert ^c   Grzela, Tomasz ^a   Kamiński, Artur ^b   Lewicki, Sławomir ^c   Skopińska Rózewska, Ewa ^a,c   Stankiewicz, Wanda ^c  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c MILITARY INSTITUTE OF HYGIENE AND EPIDEMIOLOGY   (Poland)

Author keywords

Amnion; Biological dressings; Endothelial cells; Proliferation; Radio sterilization

Indexed keywords

ALAMAR BLUE; REAGENT; UNCLASSIFIED DRUG;

AMNIOTIC DRESSING; ANIMAL CELL; ANTIANGIOGENIC ACTIVITY; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; FLUORESCENCE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; MOUSE; NONHUMAN; RADIATION STERILIZATION; TISSUE HOMOGENATE; TISSUE REGENERATION; WOUND DRESSING;

EID: 84862282817     PISSN: 14263912     EISSN: 16444124     Source Type: Journal    
DOI: None     Document Type: Article

References (59)

1. Cerqueira MT, Marques AP, Reis RL (2012): Using stem cells in skin regeneration: possibilities and reality. Stem Cells Dev (Epub ahead of print).
2. Vishnubalaji R, Manikandan M, Al-Nbaheen M, et al. (2012): In vitro differentiation of human skin-derived multipotent stromal cells into putative endothelial-like cells. BMC Dev Biol 12: 7.
3. Nomi M, Atala A, Coppi PD, Soker S (2002): Principals of neovascularization for tissue engineering. Mol Aspects Med 23: 463-483. (Pubitemid 35254100)
4. Chern PL, Baum CL, Arpey CJ (2009): Biologic dressings: current applications and limitations in dermatologic surgery. Dermatol Surg 35: 891-906.
5. Geckil H, Xu F, Zhang X, et al. (2010): Engineering hydrogels as extracellular matrix mimics. Nanomedicine (Lond) 5: 469-484.
6. Burdick JA, Prestwich GD (2011): Hyaluronic acid hydrogels for biomedical applications. Adv Mater 23: H41-56.
7. Gruss JS, Jirsch DW (1978): Human amniotic membrane: a versatile wound dressing. Can Med Assoc J 118: 1237-1254.
8. Tsai SH, Liu YW, Tang WC, et al. (2007): Characterization of porcine arterial endothelial cells cultured on amniotic membrane, a potential matrix for vascular tissue engineering. Biochem Biophys Res Commun 357: 984-990.
9. Niknejad H, Peirovi H, Jorjani M, et al. (2008): Properties of the amniotic membrane for potential use in tissue engineering. Eur Cell Mater 15: 88-99. (Pubitemid 351955733)
10. Pessolato AG, Martins Ddos S, Ambrósio CE, et al. (2011): Propolis and amnion reepithelialise sedond-degree burns in rats. Burns 37: 1192-1201.
11. Andonovska D, Dzokic G, Spasevska L, et al. (2008): The advantages of the application of amnion membrane in the treatment of burns. Prilozi 29: 183-198.
12. Ji SZ, Xiao SC, Luo PF, et al. (2011): An epidermal stem cells niche microenvironment created by engineered human amniotic membrane. Biomaterials 32: 7801-7811.
13. Dziedzic-Goclawska A, Kaminski A, Uhrynowska- -Tyszkiewicz I, Stachowicz W (2005): Irradiation as a safety procedure in tissue banking. Cell Tissue Bank 6: 201-219. (Pubitemid 41349289)
14. Riau AK, Beuerman RW, Lim LS, Mehta JS (2010): Preservation, sterilization and de-epithelialization of human amniotic membrane for use in ocular surface reconstruction. Biomaterials 31: 216-225.
15. Nakamura T, Yoshitani M, Rigby H, et al. (2004): Sterilized, freeze-dried amniotic membrane: a useful substrate for ocular surface reconstruction. Invest Ophthalmol Vis Sci 45: 93-99. (Pubitemid 38055673)
16. Singh R, Purohit S, Chacharkar MP, et al. (2007): Microbiological safety and clinical efficacy of radiation-sterilized amniotic membranes for treatment of second-degree burns. Burns 33: 505-510. (Pubitemid 46702377)
17. Thomasen H, Pauklin M, Steuhl KP, Meller D (2009): Comparison of cryopreserved and air-dried human amniotic membrane for ophthalmologic applications. Graefes Arch Clin Exp Ophthalmol 247: 1691-1700.
18. Koizumi NJ, Inatomi TJ, Sotozono CJ, et al. (2000): Growth factor mRNA and protein in preserved human amniotic membrane. Curr Eye Res 20: 173-177.
19. Niknejad H, Deihim T, Solati-Hashjin M, Peirovi H (2011): The effects of preservation procedures on amniotic membrane's ability to serve as a substrate for cultivation of endothelial cells. Cryobiology 63: 145-151.
20. Russo A, Bonci P, Bonci P (2011): The effects of different preservation processes on the total protein and growth factors content in a new biological product developed from human amniotic membrane. Cell Tissue Bank (Epub ahead of print).
21. Wolbank S, Hildner F, Redl H, et al. (2009): Impact of human amniotic membrane preparation on release of angiogenic factors. J Tissue Eng Regen Med 3: 651-654.
22. Koh JW, Shin YJ, Oh JY, et al. (2007): The expression of TIMPs in cryo-preserved and freeze-dried amniotic membrane. Curr Eye Res 32: 611-616. (Pubitemid 47400683)
23. Litwiniuk M, Bikowska B, Niderla-Bieliska J, et al (2011): High molecular weight hyaluronan and stroma-embedded factors of radiation-sterilized amniotic membrane stimulate proliferation of HaCaT cell line in vitro. Centr Eur J Immunol 36: 205-211.
24. Jiang A, Li C, Gao Y, et al. (2006): In vivo and in vitro inhibitory effect of amniotic extraction on neovascularization. Cornea 25 (10 Suppl 1): S36-40.
25. Ma X, Li J (2005): Corneal neovascularization suppressed by TIMP 2 released from human amniotic membranes. Yan Ke Xue Bao 21: 56-61.
26. Shao C, Sima J, Zhang SX, et al. (2004): Suppression of corneal neovascularization by PEDF release from human amniotic membranes. Invest Ophthalmol Vis Sci 45: 1758-1762. (Pubitemid 38868969)
27. Tombran-Tink J (2005): The neuroprotective and angiogenesis inhibitory serpin, PEDF: new insights into phylogeny, function, and signaling. Front Biosci 10: 2131-2149.
28. Marciniak K, Butwicka A, Nowak JZ (2006): PEDF: an endogenous factor displaying potent neuroprotective, neurotrophic and anti-angiogenic activity. Postepy Hig Med Dosw 60: 387-396.
29. Ma DH, Yao JY, Yeh LK, et al. (2004): In vitro antiangiogenic activity in ex vivo expanded human limbocorneal epithelial cells cultivated on human amniotic membrane. Invest Ophthalmol Vis Sci 45: 2586-2595. (Pubitemid 38998854)
30. Tyszkiewicz JT, Uhrynowska-Tyszkiewicz IA, Kaminski A, Dziedzic-Goclawska A (1999): Amnion allografts prepared in the Central Tissue Bank in Warsaw. Ann Transplant 4: 85-90.
31. Al-Nasiry S, Geusens N, Hanssens M, et al. (2007): The use of Alamar Blue assay for quantitative analysis of viability, migration and invasion of choriocarcinoma cells. Hum Reprod 22: 1304-1309. (Pubitemid 47062799)
32. Stankiewicz W, Zdanowski R, Skopińska-Różewska E, et al. (2011): The effect of 900 MHz microwave GSM signal on the proliferation of endothelial cells in vitro. Centr Eur J Immunol 36: 215-219.
33. Mo W, Yang C, Liu Y, et al. (2011): The influence of hyaluronic acid on vascular endothelial cell proliferation and the relationship with ezrin/merlin expression. Acta Biochim Biophys Sin (Shanghai) 43: 930-939.
34. Thatte S (2011): Amniotic membrane transplantation: an option for ocular surface disorders. Oman J Ophthalmol 4: 67-72.
35. Shimmura S, Shimazaki J, Ohashi Y, Tsubota K (2001): Antiinflammatory effects of amniotic membrane transplantation in ocular surface disorders. Cornea 20: 408-413. (Pubitemid 32381824)
36. Barabino S, Rolando M, Bentivoglio G, et al. (2003): Role of amniotic membrane transplantation for conjunctival reconstruction in ocular-cicatricial pemphigoid. Ophthalmology 110: 474-480. (Pubitemid 36262727)
37. Georgiadis NS, Ziakas NG, Boboridis KG, et al. (2008): Cryopreserved amniotic membrane transplantation for the management of symptomatic bullous keratopathy. Clin Experiment Ophthalmol 36: 130-135. (Pubitemid 351445145)
38. Lazzaro DR (2010): Repair of necrotizing scleritis in ulcerative colitis with processed pericardium and a Prokera amniotic membrane graft. Eye Contact Lens 36: 60-61.
39. Mehendale RA, Dagi LR (2011): Amniotic membrane implantation to reduce extraocular muscle adhesions to a titanium implant. J AAPOS 15: 404-406.
40. Kobayashi N, Kabuyama Y, Sasaki S, et al. (2002): Suppression of corneal neovascularization by culture supernatant of human amniotic cells. Cornea 21: 62-67. (Pubitemid 33144406)
41. Resch MD, Resch BE, Csizmazia E, et al. (2011): Drug reservoir function of human amniotic membrane. J Ocul Pharmacol Ther 27: 323-326.
42. Garfias Y, Zaga-Clavellina V, Vadillo-Ortega F, et al. (2011): Amniotic membrane is an immunosuppressor of peripheral blood mononuclear cells. Immunol Invest 40: 183-196.
43. Skórkowska-Telichowska K, Czemplik M, Kulma A, Szopa J (2011): The local treatment and available dressings designed for chronic wounds. J Am Acad Dermatol (Epub ahead of print).
44. Fan W, Yang Z, Luo J, et al. (2006): A comparative study on acellular small intestinal submucosa and acellular amnion as dressings for traumatic skin defects. Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi 20: 155-160.
45. Gutierrez-Moreno S, Alsina-Gibert M, Sampietro-Colom L, et al. (2011): Cost-benefit analysis of amniotic membrane transplantation for venous ulcers of the legs that are refractory to conventional treatment. Actas Dermosifiliogr 102: 284-288.
46. Tauzin H, Humbert P, Viennet C, et al. (2011): Human amniotic membrane in the management of chronic venous leg ulcers. Ann Dermatol Venereol 138: 572-579.
47. Maggio G, Armenio A, Ruccia F, et al. (2011): A new protocol for the treatment of the chronic venous ulcers of the lower limb. Clin Exp Med 12: 55-60.
48. Ley-Chávez E, Martínez-Pardo ME, Roman R, et al. (2003): Application of biological dressings from radiosterilized amnios with cobalt 60 and serologic studies on the handling of burns in pediatric patients. Ann Transplant 8: 46-49.
49. Singh R, Chacharkar MP (2011): Dried gamma-irradiated amniotic membrane as dressing in burn wound care. J Tissue Viability 20: 49-54.
50. Zmijewski M, Pietraszek A (2005): The application of deepfrozen and radiation-sterilized human amnion as a biological dressing to prevent prolonged air leakage in thoracic surgery. Ann Transplant 10: 17-20.
51. Radomska-Leśniewska DM, Skopińska-Różewska E, Malejczyk J (2010): The effect of clindamycin and lincomycin on angiogenic activity of human blood mononuclear cells. Centr Eur J Immunol 35: 217-223.
52. Jaguś P, Proczka R, Chorostowska-Wynimko J (2009): Differential regulation of endothelial cells proliferative and proangiogenic activity by sera from patients with lower limb ischemia. Centr Eur J Immunol 34: 239-242.
53. Gibka J, Skopińska-Różewska E, Wasiutyński A, et al. (2009): The effect of 4-undecanone and its derivatives on cellular and humoral immunity and tumor growth in mice. Centr Eur J Immunol 34: 29-34.
54. Gibka J, Kunicka-Styczyńska A, Gliński M (2009): Antimicrobial activity of undecan-3-one, undecan-3-ol and undec-3- yl acetate. Centr Eur J Immunol 34: 154-157.
55. Warnawin E, Burakowski T, Gajewski M, et al. (2005): Preservation of chondrogenic potential of mesenchymal stem cells isolated from osteoarthritic patients during proliferation in response to platelet-derived growth factor (PDGF). Centr Eur J Immunol 30: 26-31.
56. Hartwich M (2010): The importance of immunological studies on Rhodiola rosea in the new effective and safe herbal drug discovery. Centr Eur J Immunol 35: 263-266.
57. Sierosławska A, Rymuszka A, Siwicki AK (2008): Effects of chloramphenicol and ciprofloxacin on the selected functions of rabbit phagocytic cells. Centr Eur J Immunol 33: 43-46.
58. Szymańska-Czerwińska M, Bednarek Z, Zdzisińska B, Kandefer-Szerszen M (2009): Effect of tylosin and prebiotics on the level of cytokines and lymphocyte immunophenotyping parameters in calves. Centr Eur J Immunol 34: 1-7.
59. Skopińska-Różewska E, Strzelecka H, Wasiutynski A, et al. (2008): Aqueous and hydro-alcoholic extracts of Echinacea purpurea as traditional herbal remedies with immunotropic activity. Centr Eur J Immunol 33: 75-78.